[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619326":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":36,"collaborators":7,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":40,"sex":45,"minAge":46,"maxAge":7,"enrollmentInfo":47,"targetDuration":7,"studyType":50,"phases":7,"briefSummary":51,"conditions":52,"keywords":54,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"University Hospital, Strasbourg, France","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Victor GERBER, MD","CONTACT","33 3 68 85 37 97","victor.gerber@chru-strasbourg.fr",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Centre de référence des maladies vectorielles à tiques, CNR Borrelia - CHU de Strasbourg - France","RECRUITING","Strasbourg","67091","France","FR",{"type":23,"coordinates":24},"Point",[25,26],7.74553,48.58392,{"lat":26,"lon":25},[29,32,34],{"name":30,"role":11,"phone":12,"phoneExt":7,"email":31},"Victor Gerber, MD","victor.gerber@chru-strasbourg.frr",{"name":10,"role":33,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"name":35,"role":33,"phone":7,"phoneExt":7,"email":7},"Morgan JAMOT-DUBOIS, MD",{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100619326","factors-associated-with-mortality-in-streptococcal-anginosus-bacteremia-100619326",false,"NCT07343167","Factors Associated With Mortality in Streptococcal Anginosus Bacteremia","SGA","Inclusion Criteria:\n\n* Major subject (≥18 years old)\n* Hospitalized between January 1, 2019, and December 31, 2024, in one of the participating centers\n* Having presented during the study period at least one positive blood culture for Streptococcus anginosus, Streptococcus constellatus, or Streptococcus intermedius in a laboratory at a participating center\n\nExclusion Criteria:\n\n* Refusal to participate in the study","ALL","18 Years",{"count":48,"type":49},400,"ESTIMATED","OBSERVATIONAL","Streptococcal anginosus infections (S. constellatus, S. anginosus, and S. intermedius) are characterized by their severity, linked to high mortality and frequent infectious complications. Several studies in the literature highlight this severity, with mortality rates estimated at around 15%.\n\nThe aim of this research is to identify the factors associated with mortality in Streptococcal anginosus bacteremia.",[53],"Streptococcal Infections",[53,55,56],"Streptococcal Anginosus Bacteremia","Streptococcal anginosus infections","2026-01-06",{"date":59,"type":60},"2026-01-15","ACTUAL",{"date":62,"type":60},"2025-09-08",{"date":64,"type":49},"2027-03-08",{"name":5,"class":6},1]